|Chennai||Rs. 24020.00 (-0.17%)|
|Mumbai||Rs. 25020.00 (0.28%)|
|Delhi||Rs. 24450.00 (0%)|
|Kolkata||Rs. 24600.00 (-0.32%)|
|Kerala||Rs. 24050.00 (0%)|
|Bangalore||Rs. 24160.00 (-0.17%)|
|Hyderabad||Rs. 24030.00 (-0.12%)|
Reuters Market Eye - Shares of Indoco Remedies Ltd
This is a significant positive for the company as the sale of products from these plants should contribute 30 percent of Indoco's FY16 operating profit, brokerage Religare said in a report on Monday.
"We expect the stock's discounted multiples (vs. peers) to narrow on strong EPS growth (45% CAGR over FY14-FY17E) and improving return ratios," the note said.
(Reporting by Abhishek Vishnoi)